drugset / Trial / NCT02476864

Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults

NCT02476864

Phase 1 Completed 12 enrolled Actelion
RandomizedCrossoverOpen-labelOther

Summary

A study conducted in healthy adults to investigate if a new macitentan tablet leads to the same fate of macitentan in the body (time of onset, time of presence, amount in the blood) as the marketed macitentan tablet.

Timeline

Start
2015-08
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Macitentan Other / unclassified 10 mg Oral

Indications

No indication recorded.